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Background-—Early readmission after PCI is an important contributor to healthcare expenditures and a target for performance
measurement. The extent to which 30-day readmissions after PCI are preventable is unknown yet essential to minimizing their
occurrence.
Methods and Results-—PCI patients readmitted to hospital at which PCI was performed within 30 days of discharge at the
Massachusetts General Hospital and Brigham and Women’s Hospital were identified, and their medical records were
independently reviewed by 2 physicians. Each reviewer used an ordinal scale (0, not; 1, possibly; 2, probably; and 3, definitely
preventable) to rate clinical preventability, and a total sum score ≥2 was considered preventable. Characteristics of preventable
and unpreventable readmissions were compared, and predictors of clinical preventability were assessed by using multivariate
logistic regression. Of 9288 PCIs performed, 9081 (97.8%) patients survived to initial hospital discharge and 1007 (11.1%) were
readmitted to the index hospital within 30 days. After excluding repeat readmissions, 893 readmissions were reviewed. Fair
agreement between physician reviewers was observed (weighted j statistic 0.44 [95% CI 0.39 to 0.49]). After aggregation of
scores, 380 (42.6%) readmissions were deemed preventable and 513 (57.4%) were deemed not preventable. Common causes of
preventable readmissions included staged PCI without new symptoms (14.7%), vascular/bleeding complications of PCI (10.0%),
and congestive heart failure (9.7%).
Conclusions-—Nearly half of 30-day readmissions after PCI may have been prevented by changes in clinical decision-making.
Focusing on these readmissions may reduce readmission rates. ( J Am Heart Assoc. 2014;3:e001290 doi: 10.1161/
JAHA.114.001290)
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T he preventability of early hospital readmissions carriesimportant implications not only for patients but also for
hospitals and clinicians—as well as for payers and regulators.
The Medicare Payment Advisory Commission has recognized
hospital readmission within 30 days following an admission
during which a patient received percutaneous coronary
intervention (PCI) as an important source of Medicare
spending.1 In 2013, Medicare began to publish hospital
performance on PCI readmissions identified as unplanned on
the Hospital Compare website.2 Others have questioned the
utility of the metric, arguing that the measure may not truly
reflect the quality of care.3,4 Although the Centers for
Medicare & Medicaid Services did not include PCI in the
expansion of conditions for which centers will adjust Inpatient
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Prospective Payment System payments to hospitals in fiscal
year 2014 based on risk-standardized readmission rates,5 PCI
may become a focus in the future given the substantial
Medicare expenditures6 on PCI readmissions. Whether any
future PCI readmission measure in value-based purchasing in
the future would include PCI readmission is uncertain.
Substantial debate exists about whether tying financial
incentives to PCI readmission would enhance value and
quality in PCI care.7
One of the most important factors in assessing the value of
a quality metric is determining whether outcomes can be
enhanced by improvements in hospitals’ quality of care. This
concept is consistent with the “actionable” attribute of a
useful performance measure.8 Defining the preventability of
readmissions has been controversial, and different authors
have defined “preventability” in various ways.9–13 Because of
the inherent challenges of identifying preventable and unpre-
ventable readmissions using administrative claims data,
currently used 30-day readmission measures generally
include all readmissions, regardless of cause.
Nevertheless, understanding the preventability of readmis-
sions is critical for assessing the validity of the performance
measure, focusing resources on patients with modifiable risk,
and developing effective strategies to reduce readmissions.
Both changes in healthcare delivery systems and clinical
decision-making in individual cases have the potential to
prevent readmissions. Here, we sought to assess clinical
preventability of 30-day readmissions following PCI.
Methods
Study Population
We studied patients in the Partners PCI Readmission Project,
which is a database created from readmissions within 30 days
of PCI within the Partners Healthcare system in Boston,
Massachusetts. Causes of readmission in the study cohort
have been described previously.14 Partners Healthcare is an
integrated healthcare system founded in 1994 by Massachu-
setts General Hospital (MGH) and Brigham and Women’s
Hospital (BWH), the 2 largest hospitals affiliated with Harvard
Medical School. The network currently includes 8 Massachu-
setts hospitals, 21 community health centers, and a network
of independent ambulatory practices with >500 affiliated
primary care physicians. Three of the hospitals are PCI
capable, 2 of which (MGH and BWH) comprise 88.8% of the PCI
procedures performed within the entire healthcare network.
PCIs performed at the MGH or BWH were included in this
analysis.
Data were available for all patients who received PCI at
BWH during June 2009 to December 2011 and at MGH during
January 2007 to December 2011. PCI procedures were then
linked to hospital administrative discharge and admission
data to determine which patients were readmitted to the
hospital at which PCI was performed within 30 days of
discharge. To ensure complete access to the hospital records
for the readmission hospitalization, only readmissions to the
index hospital were considered, which constitute about two-
thirds of all readmissions after PCI.14 For this study, only the
first readmission within 30 days for each PCI was included.
For example, if a patient received PCI during a first admission,
received repeat PCI during a readmission, and then was
admitted to the hospital for a third time (a second readmis-
sion), only the first readmission was included.
Chart Review and Data Analysis
The determination of preventability by retrospective chart
review is inherently subjective and has not been well defined.
In that context, we used 2 or 3 different reviewers from
different specialties to gain insight into the disagreements
between physicians about preventability and to establish
standards for our research.
For this analysis, we sought to identify readmissions that
were “clinically preventable”—defined as those preventable
by a change in clinical decision-making by a clinician under
the current standards of care. In most cases, this change in
clinical decision-making would be expected to lead to the
prevention or amelioration of the process that led to
readmission. Readmissions that could have been prevented
by reorganization of the health system, changes in current
standards of care, or the addition of clinical resources were
not considered preventable for the purposes of this analysis.
Two physicians (JHW, a cardiologist, and JBS, an internist)
initially reviewed medical records of all eligible patients and
independently assigned a clinical preventability rating accord-
ing to a classification system (Figure 1). This system catego-
rized the preventability ratings for readmissions, and we then
refined the system after an exploratory review of the first 50
cases. Examples of representative but fictional cases in each
category appear in the Appendix. “Not preventable” readmis-
sions are due to factors not related to the index admission or
the PCI procedure or due to an unavoidable consequence of the
PCI procedure. “Possibly preventable” readmissions could
have been foreseen by an astute clinician and possibly could
have been prevented by changing care during the index
admission, discharge, or postdischarge period. “Probably
preventable” readmissions may have been averted had the
procedural or postprocedural care (femoral versus radial,
choice of angioplasty balloon size, choice of antiplatelet
therapy) been different. “Definitely preventable” readmissions
clearly could have been avoided with appropriate care,
counseling, or coordination, given the current standards of
care. Scheduled readmissions within 30 days were considered
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“definitely preventable,” unless a clinical reason to schedule
the readmission within 30 days was identified. Interobserver
agreement was evaluated using a weighted j statistic.
The classification system was converted to an ordinal rank
system (0=not preventable, 3=definitely preventable) and the
ordinal rankings of the 2 physician reviewers were added to
provide a composite ranking (0=least preventable, 6=most
preventable). In the composite ranking, we elected to
consider readmissions with scores ≥2 as “preventable.” All
other readmissions, those with composite scores of 1 or 0,
were considered not preventable. We then compared baseline
patient and procedural characteristics for preventable versus
nonpreventable readmissions, including baseline risk of
readmission as assessed by a previously validated prediction
model.15 Multivariable logistic regression was used to deter-
mine “independent” predictors of possible preventability. To
test the effect of dichotomizing the variable, as a sensitivity
analysis, predictors of preventability using the 0-to-6 scale as
a continuous variable in linear regression was performed.
In addition to independent reviews by 2 physicians for all
readmissions, the records of patients readmitted with stent
thrombosis, vascular or bleeding complications of PCI, myo-
cardial infarction on readmission, or repeat PCI on readmission
were reviewed independently by an interventional cardiologist
(SWW) with an identical classification scheme focusing only on
technical and procedural aspects of the index PCI that may led
to readmission. Finally, the medical records of all readmissions
deemed preventable were then rereviewed to determine how
the readmission might have been prevented, and results were
tabulated. We developed this method of assessing prevent-
ability based on independent review of multiple physicians
because previous studies have shown wide variation in
agreement between physician chart reviewers in assessment
of the preventability of readmission.9,10,16,17 Although this
method is time-intensive, we believe that capturing the
opinions of multiple physicians creates a more objective
standard for an inherently subjective assessment.
All analyses were performed using SAS version 9.3 (SAS
Institute). Categorical variables were compared using the v2
test, and continuous variables were compared using the
Student t test. The association between reasons for readmis-
sion and preventable readmissions was assessed by a v2
trend test. A value of P<0.05 was considered statistically
significant.
The institutional review board at Partners Healthcare
approved this study. Because the project involved retrospec-
tive review of medical records, the need for informed consent
was waived.
Results
During the time periods of the study, 9288 PCI procedures
were performed on 7773 unique patients. Patients were alive
on hospital discharge following 9081 PCI procedures (97.8%).
Of 1007 readmissions, 893 (9.8% of patients surviving initial
discharge) met inclusion criteria, representing 852 unique
patients. A flow chart for excluded and included PCIs appears
in Figure 2. Detailed causes of readmission ascertained by
physician chart review in this dataset have been previously
reported14 and are listed in the Appendix.
Preventability Ratings for 2 Reviewers
One reviewer rated 600 (67.2%) readmissions as “not
preventable,” 59 (6.6%) as “possibly preventable,” 83 (9.3%)
as “probably preventable,” and 151 (16.9%) as “definitely
preventable.” The second reviewer rated 476 (53.4%) read-
missions as “not preventable,” 115 (12.9%) as “possibly
preventable,” 107 (12.0%) as “probably preventable,” and 195
(21.8%) as “definitely preventable.” A full categorization of the
Not preventable: A clinician could not have prevented the 
readmission.  Readmission due to factors not related to the index 
admission or the PCI procedure, or due to an unavoidable 
consequence of the PCI procedure.
Possibly preventable: An astute clinician could have foreseen the 
readmission and possibly could have prevented the readmission by 
changing care during the index admission, discharge, or post-
discharge.
Probably preventable: Performing the procedure or post-
procedural care differently (femoral vs. radial, choice of antiplatelet
therapy) may have averted the readmission.
Definitely preventable: The readmission could have clearly been 
avoided with appropriate care or counseling.  Scheduled 
readmissions within 30 days are definitely preventable, unless a 
clinical reason exists to schedule the readmission within 30 days.
Figure 1. Definitions of Preventability Categories.
9288 PCIs performed 
1011 day readmissions 
identified on initial screen
1007 confirmed as 
readmissions by chart 
review
893 30 day readmissions met 
inclusion criteria (not repeat 
readmissions)
8277 not followed by 30 day 
readmission on initial screen 
4 erroneously identified as 
readmissions in hospital 
admission data
113 repeat readmissions
Figure 2. Flow chart for excluded and included percutaneous
coronary interventions (PCIs) in the creation of the database.
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preventability ratings appears in Figure 3. The weighted j was
0.44 (95% CI 0.39 to 0.49), indicating fair agreement between
physician reviewers.
Although both reviewers agreed that 407 (45.6%) cases
were “not preventable,” the remaining 486 (54.4%) cases
were rated at least possibly preventable by at least 1 of the 2
reviewers. At least 1 reviewer rated 247 (27.6%) cases as
“definitely preventable,” and both reviewers rated 99 (11.1%)
readmissions as “definitely preventable.” Examples of
reviewer ratings and disagreements can be found in the
Appendix.
Composite Ratings and Risk of Readmission
In the composite rankings (combined preventability score ≥2),
380 (42.6%) readmissions were classified as preventable and
513 (57.4%) as not preventable. Patient characteristics of
these 2 groups are shown in Table 1. Preventable readmis-
sions were more likely in patients with peripheral arterial
disease (29.7% versus 21.6%, P=0.006), renal insufficiency
(glomerular filtration rate 62.7 versus 70.4 mL/min per
1.73 m2, P<0.001), diabetes (46.1% versus 36.3%,
P=0.003), heart failure (29.2% versus 23.0%, P=0.036), and
older patients (68.3 years versus 65.8 years, P=0.004).
Preventable readmissions were also more common following
elective procedures (23.2% versus 15.4%) and for ambulatory
patients (32.6% versus 25.2%, P=0.049). The mean predicted
risk of readmission for the preventable readmissions based on
a previously developed PCI readmission risk model15 was
16.9% compared with 16.2% for not preventable readmissions
(P=0.261). After multivariable adjustment, only diabetes,
glomerular filtration rate, prior PCI, and elective index PCI
procedure were associated with preventable readmissions
(Figure 4). Model results were similar when treating prevent-
ability score as a continuous variable, and therefore only the
primary analysis is presented here.
Technical and Procedural Factors
Of all readmissions, 121 were due to stent thrombosis,
myocardial infarction, vascular or bleeding complications, or
the requirement for repeat coronary revascularization and
were thus reviewed for technical and procedural factors
related to readmission. This review identified 9.9% (12/121)
of cases as at least possibly preventable through technical
changes in the procedure that were rated not otherwise
preventable in the main analysis. All of these involved patients
who had recurrent symptoms after discharge and received
repeat PCI of a different lesion during readmission. Further-
more, 14.0% (17/121) of cases were rated as not preventable
from a technical standpoint but at least possibly preventable
through other changes in medical care in the main analysis. Of
those 17 cases, 5 were due to medication noncompliance that
could have been prevented by caregivers or inability to
obtain an outpatient appointment, 4 were due to subopti-











408 (45.6%) 81 (9.1%) 46 (5.1%) 66 (7.4%)
Possibly 
preventable
25 (2.8%) 10 (1.1%) 13 (1.5%) 11 (1.2%)
Probably 
preventable
24 (2.7%) 9 (1.0%) 31 (3.5%) 19 (2.1%)
Definitely 
preventable
20 (2.2%) 15 (1.7%) 17 (1.9%) 99 (11.1%)





Figure 3. Preventability ratings of 2 reviewers
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preventable because a less potent antiplatelet agent was used
in stent thrombosis cases. In the remaining 5 cases, the
procedural reviewer rated a case not preventable that was
believed to be at least possibly preventable by the noninter-
ventional physician through changes in procedural technique
or decision-making.
Association With Cause of Readmission
A plurality of preventable readmissions were due to staged
PCI without new symptoms (56, 14.7% of preventable
readmissions), followed by vascular/bleeding complications
of PCI (38, 10.0%), congestive heart failure (37, 9.7%), chest
pain or other symptoms concerning for angina (32, 8.4%), and
stent thrombosis (21, 5.5%). Preventable and nonpreventable
readmissions, listed by cause of readmission, appear in
Table 2.
Tactics to Prevent Preventable Readmissions
Of the 380 preventable readmissions, the greatest proportion
(130/380, 34.2%) could have been prevented by performing
an elective procedure at a different time, potentially during
the index admission. Other ways that a preventable readmis-
sion could have been averted included different medical
management (110/380, 28.9%), better access to outpatient
care (39/380, 10.3%), or performing a procedure differently
(39/380, 10.3%), such as avoiding or treating a stent-
associated edge dissection. Improved communication (32/
380, 8.4%) and prevention of vascular access complications
(30/380, 7.9%) also accounted for some ways in which
preventable readmissions could have been averted.
Discussion
In a detailed review of 893 consecutive readmissions within
30 days of discharge for PCI, we found that nearly half of
readmissions are preventable and that >1 of 10 were
Table 1. Characteristics of Readmitted Patients, Separated






Age, meanSD y 68.311.5 65.813.8 0.004





Black 18 (4.7%) 27 (5.3%)
Hispanic 13 (3.4%) 23 (4.5%)
White 333 (87.6%) 445 (86.7%)
Asian 14 (3.7%) 14 (2.7%)
Native American 0 1 (0.2%)
Other 2 (0.53%) 3 (0.58%)
Admission status, % 0.049
Emergency
department
137 (36.1%) 207 (40.4%)
Transfer from
acute care
119 (31.3%) 177 (35.5%)
Other 124 (32.6%) 129 (25.2%)
Insurance, % 0.928
Government 225 (59.2%) 294 (57.3%)
Commercial 102 (26.8%) 148 (28.9%)
HMO 45 (11.8%) 59 (11.5%)
None 5 (1.3%) 9 (1.8%)
Non-US insurance 3 (0.8%) 3 (0.6%)
Prior MI >7 days, % 158 (41.6%) 203 (39.6%) 0.546
CHF history, % 111 (29.2%) 118 (23.0%) 0.036
Prior valve surgery, % 20 (5.3%) 17 (3.3%) 0.148
Prior PCI, % 134 (35.3%) 199 (38.8%) 0.281
Prior CABG, % 82 (21.6%) 105 (20.5%) 0.687
Diabetes, % 175 (46.1%) 186 (36.3%) 0.003
GFR, mL/minSD 62.7  26.5 70.4  31.0 <0.001
Hypertension, % 330 (86.8%) 427 (83.2%) 0.138
Dyslipidemia, % 359 (94.5%) 488 (95.1%) 0.662
CVD, % 88 (23.2%) 114 (22.2%) 0.741
PAD, % 113 (29.7%) 111 (21.6%) 0.006
Chronic lung disease, % 79 (20.8%) 106 (20.7%) 0.963
Arterial access site 0.503
Femoral, % 333 (87.6%) 431 (84.0%)
Brachial, % 3 (0.8%) 6 (1.2%)
Radial, % 37 (9.7%) 64 (12.5%)
PCI status < 0.001








Urgent, % 208 (54.7%) 341 (66.5%)
Emergency, % 81 (21.3%) 93 (18.1%)
Salvage, % 3 (0.8%) 0
Drug eluting
stent used, %
167 (49.7%) 253 (52.7%) 0.398
HMO indicates health maintenance organization; MI, myocardial infarction; CHF,
congestive heart failure; PCI, percutaneous coronary intervention; CABG, coronary artery
bypass graft surgery; GFR, glomerular filtration rate; CVD, cerebrovascular disease; PVD,
peripheral vascular disease.
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considered “definitely preventable” by 2 independent review-
ers. Staged PCI, vascular access complications, congestive
heart failure, and elective vascular surgeries and procedures
were the most common causes of preventable readmissions.
Our results suggest that clinicians and hospitals might reduce
readmission rates by avoiding reflexive staged procedures in
the absence of new or persistent clinical symptoms, carefully
avoiding vascular access complications and bleeding through
methods such as transradial access, careful titration of
medications for heart failure patients, and minimizing the risk
of stent thrombosis through careful technique and intensifi-
cation of dual antiplatelet therapy in selected high-risk
patients. Despite these opportunities for improvement, our
results also suggest that the majority of readmissions would
not be prevented with simple changes in clinical decision-
making. In addition, our study showed only moderate
agreement among physicians about the likelihood that a
given readmission could be prevented, illustrating the
subjective nature of such an assessment despite attempts
to standardize definitions between reviewers.
Prior literature on assessing the preventability of PCI
readmissions is sparse. A study from Geisinger Medical
Center identified readmissions within 30 days after PCI and
determined cause of readmission via physician record
review.4 In that work, Yost et al determined that only 11.9%
of readmissions were due to complications of the PCI
procedure and that 40.2% were unrelated to the index
admission. They concluded that this low rate of readmission
for PCI complications does not support the use of readmission
after PCI as a quality metric of the index admission. Our data
confirm and extend these results. In particular, we also have
shown a very low rate of readmissions related to technical
complications of the PCI procedure.14 By seeking to define
preventability, as opposed to relation to the index admission,
however, we have characterized readmissions differently. In
particular, the 42.6% of preventable readmissions offer
Odds ratio
0.25 0.5 1 2 4
Drug-eluting stent used
Urgent PCI status (ref. emergency)
Elective PCI status (ref. emergency)














No Insurance (ref. commercial)
HMO insurance (ref. commercial)
Government insurance (ref. commercial)
Admission status: Transfer (ref. other)
Admission status: Emergency (ref. other)






























<<<Less Likely Preventable More Likely Preventable>>>
Figure 4. Factors associated with possible preventability for 30-day readmission among readmitted
patients. CABG indicates coronary artery bypass graft surgery; CVD, cerebrovascular disease; GFR,
glomerular filtration rate; PCI, percutaneous coronary intervention; HMO, health maintenance organization;
PAD, peripheral vascular disease.
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potential opportunities for reducing 30-day readmissions
after PCI.
To minimize the subjectivity inherent in such an analysis,
we narrowed our definition of preventability to include only
those readmissions that might have been prevented through
changes in clinical decision-making within the current rubric
of healthcare delivery. In doing so, we may not be
accounting for readmissions that could be preventable
through changes in healthcare systems. For example, we
have previously shown that symptoms concerning for angina
prompt a plurality of early readmissions following PCI,
although few patients have myocardial infarction or require
repeat PCI.14 As such, we and others18 have proposed that
redesigning care systems may allow alternative management
such as outpatient care for some of these patients,
preventing some readmissions. For this study, we deliber-
ately avoided including readmissions for which improve-
ments in technology, such as more effective telemonitoring,
or innovations in care delivery, such as chest pain units that
could accommodate patients after PCI, could have averted
the readmission.
Studies using clinical chart review to assign subjective
preventability have used a variety of methods. Some studies
have defined a readmission as preventable only if multiple
chart reviewers deemed the readmission preventable,9 and
others have used a third reviewer as a “tie-breaker” to
adjudicate disagreements.10 Still others have predefined
clinical circumstances that constitute a preventable readmis-
sion,11,12 or trained physician reviewers with common prin-
ciples.13 We have demonstrated only fair agreement
(weighted j=0.44) between 2 physician reviewers with nearly
1 in 10 rated “definitely preventable” by one reviewer and
“not preventable” by the other reviewer. These findings
highlight the subjectivity inherent in these assessments and
are within the range of previous studies on preventability of
readmission by chart review. Studies of the preventability of
general medical readmissions show wide variance in interob-
server variation from excellent9,10 to poor.16 One study of
pediatric readmissions found that multiple reviewers initially
disagreed about preventability in 62.5% of cases.17 Given the
substantial heterogenity in past work with respect to assess-
ing preventability and given the wide range in interobserver
variation reported in previous studies, we decided to use
multiple independent physician reviewers in assessing pre-
ventability in this study. The 3M Health Information Systems
Potentially Preventable Readmissions Classification System,
which is a classification based on coded discharge diagnoses,
avoids this subjectivity by defining combinations of diagnosis
billing codes that constitute preventable readmissions.19,20
The 2007 Medical Payment Advisory Commission report to
the US Congress used the 3M methodology to conclude that
13.3% of Medicare readmissions are preventable.1 We believe
our results showing disagreement among physicians using
standardized evaluation of clinical records should raise
skepticism that an automated system derived from adminis-
trative claims data could accurately identify preventable
readmissions. We also believe that our results may suggest
that financial penalties based on billing code algorithms
identifying “preventable” readmissions may not be effective
and support a shift to assessing “all-cause” readmissions.
We have also shown that preventability of readmission
does not correlate with the predicted risk of readmission as
calculated by a validated risk model. The mean risk of
readmission for the patients who had preventable readmis-
sions was 16.9%, and the mean risk of readmission for the
patients who had nonpreventable readmissions was 16.2%
(P=0.261). As such, high-risk patients are at high risk of both
preventable and nonpreventable readmissions. Since high-risk
patients are at higher risk of preventable readmissions—
despite the fact that they are also at higher risk of
nonpreventable readmissions—interventions targeting these
Table 2. Preventable and Not Preventable Readmissions, as
Determined by the Dichotomized Rating, Listed by Reason for








Staged PCI without new
symptoms
56 (14.7%) 3 59
Vascular/bleeding complication
of PCI
38 (10.0%) 1 39
Congestive heart failure 37 (9.7%) 16 53
Chest pain or other symptoms
concerning for angina
32 (8.4%) 309 341
Stent thrombosis 21 (5.6%) 1 22
Elective peripheral procedure/
surgery unrelated to PCI
20 (5.2%) 0 20
Elective CABG 19 (5.0%) 0 19
Syncope or presyncope 14 (3.7%) 8 22
Atrial fibrillation 6 (1.6%) 6 12




5 (1.3%) 13 18
Aortic stenosis 5 (1.3%) 4 9
Venous thromboembolism 5 (1.3%) 3 8
Bacteremia or endocarditis 5 (1.3%) 2 7
Categories with <5
preventable cases
111 (29.2%) 143 287
CABG indicates coronary artery bypass graft surgery; PCI, percutaneous coronary
intervention; TIA, transient ischemic attack.
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patients may still be more likely to yield effective results. We
believe that this result should therefore support the identi-
fication and targeting of higher-risk patients for interventions.
We have also found that specific reasons for readmission
are associated with different degrees of preventability, which
has important implications for strategies to reduce readmis-
sions. Our intention in this analysis was to identify reasons
why patients are being readmitted and which readmissions
could plausibly be prevented, even if those mechanisms do
not all improve value for patients. This type of broad
assessment is important for understanding the overall utility
of PCI readmission as a quality metric. In particular,
performing staged PCI or coronary artery bypass graft surgery
during a single admission and deferring staged PCI unless a
patient has persistent symptoms have uncertain implications
for quality and value. Potential for manipulation—for example,
scheduling a planned procedure >30 days after a PCI
discharge—highlights a weakness of all-cause PCI readmis-
sion as a quality metric.
Other categories of readmissions offer clearer opportuni-
ties for care improvement, however. Although not common,
procedural and bleeding complications of PCI, including stent
thrombosis, were also associated with high preventability.
Congestive heart failure exacerbations and episodes of
syncope/presyncope were more common, and many were
considered preventable. Careful titration of medications
before discharge and early follow-up of patients susceptible
to syncope, presyncope, and congestive heart failure exacer-
bations may offer an opportunity to improve care. Other types
of readmissions associated with low clinical preventability,
such as chest pain after PCI, may still be associated with
higher nonclinical preventability, such as establishing chest
pain units with the capacity to accept patients with recent
PCI. Both clinical and nonclinical preventability may enhance
improvements in performance on this quality metric. We
believe that even a minimalist interpretation of our results—
that only the 11% of readmissions rated as “definitely
preventable” by 2 independent physicians are actually
preventable—supports the role of PCI readmission as a
quality metric. Although some readmissions were rated more
preventable because of patient noncompliance, PCI readmis-
sion as a performance metric will engage hospitals and
physicians to work with patients to enhance compliance. The
metric could also improve prospective shared decision-
making, such as avoiding drug-eluting stents in patients who
have a history of medical noncompliance and/or patients who
doubt their own ability to reliably manage prolonged dual-
antiplatelet therapy.
Our results should be interpreted in the context of several
important limitations. First, as a study of a particular health
system, the extent to which we can generalize our findings to
other hospitals and healthcare systems is unclear. Second,
the retrospective assessment of preventability from chart
review is inherently subjective and offers a lower standard of
evidence than prospective trials that could prove specific care
innovations reduce readmissions. We view our results as
hypothesis-generating; as such, the tactics we have identified
should be prospectively tested. In particular, the proportion of
“preventable” cases would have changed had we lowered or
raised the point threshold for preventability in the dichoto-
mized ranking. Third, we were not able to review medical
records from the readmission of patients readmitted to a
different hospital than the hospital at which PCI was
performed, which may limit the generalizability of our findings.
We have previously established that over two-thirds of
patients in this health system who are readmitted within
30 days are readmitted to the index hospital. The major
difference in readmissions to nonindex hospitals is that
patients are more likely to be readmitted with heart failure
(13.8% versus 7.1%, P=0.003)14 than are readmissions to the
index hospital. Since heart failure readmissions were associ-
ated with high preventability (69.8%), our results may
underestimate overall preventability. Fourth, we cannot know
from retrospective chart review if preventing the readmission
(eg, using a more potent antiplatelet agent to prevent stent
thrombosis) would have led to another unforeseen complica-
tion (eg, bleeding). Fifth, we cannot be certain about the
extent to which we can extrapolate our findings to the
conditions (acute myocardial infarction, congestive heart
failure, and pneumonia) that are currently included in value-
based purchasing, although many of the patients who are
admitted with acute myocardial infarction and congestive
heart failure are likely also receiving PCI during the index
admission. Sixth, by including elective and staged PCI in our
database, our data differ from the current PCI readmission
metric reported on Hospital Compare. The reported readmis-
sion metric excludes planned readmissions based on an
algorithm based on billing codes. The Hospital Compare
algorithm first excludes readmissions for organ transplanta-
tion, then identifies procedural readmissions, and excludes
them if the discharge is not either an acute medical issue or a
procedural complication. We created the database including
elective readmissions because the extent to which a billing
code algorithm corresponds with physician-adjudicated chart
review is unclear. Furthermore, whether any future PCI
readmission metric in value-based purchasing might include
elective readmissions is uncertain. Seventh, since we
reviewed medical records for readmitted patients, we do not
have information about opportunities to improve quality of
care for patients who were not readmitted. Although this was
out of scope for the present analysis, this is an important
issue that merits investigation. Finally, our definition of
preventability did not include use of wider health systems
reforms or changes in standards of care, such as raising
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readmission thresholds for post-PCI patients, that might
effectively reduce readmission rates.
In conclusion, we have demonstrated that nearly half of 30-
day readmissions after PCI episodes may be clinically
preventable. Clinicians can use these results to reduce
readmissions, often in ways that enhance value and quality.
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Appendix
Theoretical Examples of Readmissions
in Different Preventability Categories
Not Preventable
A 65 year old man admitted initially for ST-segment elevation
myocardial infarction and discharged from the hospital is
readmitted within 2 weeks following a motor vehicle accident.
An 84 year old woman underwent PCI for STEMI and then
was readmitted 28 days after discharge for community-
acquired pneumonia.
Possibly Preventable
A 72 year old woman with an LVEF of 46% following NSTEACS
but euvolemic on discharge is readmitted within 3 weeks for
congestive heart failure without an outpatient visit.
A 48 year old man following PCI for STEMI had a beta-
blocker added during the index hospitalization felt well
ambulating prior to discharge, but was readmitted to the
hospital 3 days after discharge for syncope and orthostatic
hypotension.
Probably Preventable
A 51 year old diabetic man, with no history of bleeding or
stroke, following STEMI that was treated with bifurcation
stenting in the proximal LAD and first diagonal, discharged on
aspirin and clopidogrel (rather than prasugrel or ticagrelor)
and is readmitted with stent thrombosis after 20 days.
A 63 year old woman underwent PCI for unstable angina
from the femoral approach and was readmitted with a
symptomatic pseudoaneursym of the femoral artery.
Definitely Preventable
A 74 year old man with mild muscle aches and elevated CK
during the index hospitalization attributed to his new high
dose statin is discharged with a plan for outpatient follow up,
but is readmitted in 1 week with rhabdomyolysis.
A 70 year old ambulatory man who walks every day
without angina undergoes elective PCI of his distal left
circumflex artery “just to get him through” an elective repair
of an aortic aneurysm and then is readmitted 2 weeks after
the PCI for aortic aneurysm surgery.
Example of Disagreement (1)
A 66 year old woman with class 3 stable angina despite
appropriate medical management has severe lesions of both
the right coronary artery and the left circumflex artery. Both
lesions have fractional flow reserve assessed suggesting
ischemia, and the right coronary artery is stented. The patient
continues to have angina after discharge, and she is
readmitted for stenting of the circumflex lesion with
subsequent relief of symptoms. Reviewer A thinks that this
case is probably preventable, because the other lesion could
have been stented during the index procedure, per the results
of randomized clinical trials. Reviewer B thinks that this case
is not preventable, because there was no way that the
operator could have known which lesion was responsible for
the symptoms, and a reasonable approach was to stent one of
the vessels and follow the clinical response.
Example of Disagreement (2)
A 78 year old man with STEMI treated with angioplasty and
placement of a drug-eluting stent to the LAD has a stroke
2 days after the procedure. Complications of the stroke lead
to a readmission. After review of the angiogram and clinical
documentation, reviewer A finds no evidence of procedural
complications, and concludes that the timing of the stroke is
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coincidental. Reviewer A therefore rates the readmission as
not preventable. Reviewer B agrees with the interpretation of
the clinical data, but thinks that the timing of the stroke is not
likely coincidental, and therefore rates the case as possibly
preventable.
Example of Disagreement (3)
A 92 year old man with chronic hip arthritis has a NSTEMI
treated with a drug eluting stent to the RCA. Three weeks
after discharge, his chronic opioid medications cause severe
constipation requiring hospitalization. Reviewer A rates the
case as definitely preventable because the symptoms had
been worsening in the outpatient setting for 3 days. Reviewer
B rates the case as not preventable because the patient had
intractable pain that required narcotics, and constipation is a
known side effect. Neither Reviewer A nor Reviewer B think
the readmission had anything to do with the PCI procedure,
although they still disagree on preventability.
Example of Disagreement (4)
A 67 year old man with chronic heart failure received PCI for
stable angina. His beta blockers were uptitrated during the
hospital stay, with vital signs in an appropriate range at
discharge and without symptoms. He then was readmitted
with syncope 2 weeks later due to bradycardia. Reviewer A
rates the case as only possibly preventable given the
appropriate indication for uptitration of the beta blocker and
Reviewer B rates the case as definitely preventable given the
known side effect of beta blockers, saying that better
inpatient assessment and/or outpatient monitoring is sure
to have prevented the medication-related readmission.




Chest pain or other symptoms
concerning for angina
341 (38.1%)
Staged PCI without new symptoms 59 (6.6%)
Congestive heart failure 53 (5.9%)
Vascular/bleeding complication of PCI 39 (4.4%)
Gastrointestinal hemorrhage 28 (3.1%)
Stent thrombosis 22 (2.5%)
Syncope or presyncope 22 (2.5%)
Elective peripheral procedure or
surgery not related to PCI
20 (2.2%)
Elective CABG 19 (2.1%)
Cholecystitis, colitis/enteritis, pancreatitis,







Atrial fibrillation 12 (1.3%)
Urinary tract infection or urosepsis 11 (1.1%)
Stroke or TIA (not related to PCI) 10 (1.1%)
Aortic stenosis 9 (1.0%)
Venous thromboembolism 8 (0.9%)
Ventricular tachycardia 8 (0.9%)
Bacteremia or endocarditis 7 (0.8%)










Chronic obstructive lung disease 4 (0.4%)
Hematuria 4 (0.4%)
Anxiety, depression, or panic attack 4 (0.4%)
Hypotension 4 (0.4%)
Fever 4 (0.4%)
Elective ICD placement 4 (0.4%)
Renal failure 4 (0.4%)
Causes with fewer than 4 cases
(listed below)
133 (14.9%)
Abdominal pain (2), abscess, acute peripheral ischemia not
related to catheterization, accelerated idioventricular rhythm,
acute renal failure, alcohol withdrawal, allergic reaction to
unclear source, allergic reaction to contrast dye, allergic
reaction to cefepime, allergic reaction to hydralazine, allergic
reaction to non-steroidal anti-inflammatory agent, allergy to
plavix (2), altered mental status, amputation not related to
catheterization (2), anemia without bleeding (2), arm hematoma
not related to catheterization, arm pain after receiving pneu-
movaccine, arthritis, atrial flutter, chronic back pain (2), back
pain after motor vehicle accident, beta blocker toxicity (3),
biliary stent occlusion, elective bladder fulguration, bladder
spasm due to urinary catheter, tongue bleeding, epistaxis,
endometrial bleeding, uterine fibroid, bradycardia (3), broken
tooth, bursitis, cellulitis, elective chemotherapy admission (3),
non-sustained ventricular tachycardia, elective dilatation and
curettage for endometrial cancer, dehydration (3), diabetic
neuropathy, dialysis line infection, digoxin toxicity, diabetic
ketoacidosis (2), dysarthria, dyspnea, elective tricuspid valve
annuloplasty/mitral commissurotomy/aortic valve replace-
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ment, elective resection of a retroperitoneal sarcoma, elective
placement of a cardiac resynchronization device, elective
electrophysiologic study, elective implanted cardioverter-defi-
brillator device (3), elective mediastinoscopy, elective mitral
valve replacement, elective percutaneous tricuspid valve
replacement, elective pacemaker placement, elective trans-
catheter aortic valvular replacement (2), elective total hip
replacement, elective closure of a ventricular septal defect,
encephalopathy, endomyocardial biopsy, failure to thrive,
fatigue (2), hypotension, gangrene, gastroparesis, headache
(3), hemorrhagic conversion of periprocedural stroke, hemopt-
ysis, hernia, hospice admission, hyperglycemia, hypertension
(3), hypoglycemia (2), hyponatremia, intracerebral hemorrhage,
infected dialysis fistula (2), interstitial lung disease, large bowel
obstruction, leukemia exacerbation, lithium overdose, loss of
consciousness during dialysis, mechanical fall, migraine, mis-
placed nasogastric tube, nausea, paresthesias (2), non-healing
vascular bypass graft, orthostasis (2), osteomyelitis (3), pace-
maker bleeding, palpitations (2), panniculitis, pericardial effu-
sion (2), peritonitis related to a peritoneal dialysis catheter,
wound infection, pleural effusion (2), poor oral intake, progres-
sion of lung cancer, pseudogout, premature ventricular con-
tractions, pulmonary tuberculosis, evaluation for cardiac
transplantation, seizure, shortness of breath, slurred speech,
spinal fusion, elevated INR without bleeding, superficial phle-
bitis, surgical site infection after hip surgery, tachycardia,
tamponade, thrombotic occlusion of peripheral vascular graft,
thyrotoxicosis, heart transplant, gastric ulcer, need for urgent
dialysis, urgent peripheral arterial procedure not related to
catheterization, placement of a ventricular assist device,
vomiting (2), mitral stenosis.
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